½ÃÀ庸°í¼­
»óǰÄÚµå
1417397

¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2030³â)

Bladder Cancer Detective Kit Market Report: Trends, Forecast and Competitive Analysis to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Lucintel | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 - page report | ¹è¼Û¾È³» : 3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹æ±¤¾Ï °ËÃâ ŰƮ µ¿Çâ°ú ¿¹Ãø

¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö CAGR 11.8%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö ¾à 4¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹æ±¤¾Ï À¯º´·ü Áõ°¡, ÇコÄÉ¾î ºñ¿ë ±Þµî, ´ã¹è ¼Òºñ·® Áõ°¡ÀÔ´Ï´Ù. ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø¡¤Áø·á¼Ò ¹× Áø´Ü ¼¾ÅÍ ½ÃÀå¿¡¼­ÀÇ ±âȸ¿¡ ÀÇÇØ À¯¸ÁÇØ º¸ÀÔ´Ï´Ù.

¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå ÀλçÀÌÆ®

LucintelÀº FISH(Fluorescent In Situ Hybridization)°¡ ¿¹Ãø±â°£ µ¿¾È ÃÖ´ë ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß¿¡¼­ »ç¿ëµÇ´Â »õ·Î¿î ¼Òº¯ °Ë»ç ±â¼úÀº Á÷Á¢ Ç¥Áö µÈ Çü±¤ DNA ÇÁ·Îºê¸¦ »ç¿ëÇϰí, ¼Òº¯À» Æ÷ÇÔÇÑ ¿ä·Î »óÇÇ ¼¼Æ÷ À¯ÀüÀÚ ÀÌ»óÀ» Á¶»çÇϱ⠶§¹®ÀÔ´Ï´Ù.

ÀÌ ½ÃÀå¿¡¼­´Â ¼¼°èÀÇ º´¿ø ÀÎÇÁ¶ó Áøº¸¿¡ ÀÇÇØ º´¿ø¡¤Áø·á¼Ò°¡ ÃÖ´ë ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î »ý°¢µË´Ï´Ù.

ºÏ¹Ì´Â ÀÌ Áö¿ªÀÇ ¹æ±¤¾Ï ÀÌȯÀ² Áõ°¡¿¡ ÀÇÇØ ¿¹Ãø±â°£ µ¿¾È ÃÖ´ë Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1. ½ÃÀå ±Ô¸ð´Â?

A1. ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀåÀº 2030³â±îÁö ¾à 4¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q2. ½ÃÀå ¼ºÀå ¿¹ÃøÀº?

A2. ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 11.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Q3. ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº?

A3. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹æ±¤¾Ï À¯º´·ü Áõ°¡, ÇコÄÉ¾î ºñ¿ë ±Þµî, ´ã¹è ¼Òºñ·® Áõ°¡ÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

A4. ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå Àü¸ÁÀº º´¿ø¡¤Áø·á¼Ò ½ÃÀåÀ̶ó°í Áø´Ü ¼¾ÅÍ ½ÃÀåÀÇ ±âȸ¿¡ ÀÇÇØ À¯¸Á½Ã µË´Ï´Ù.

Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

A5. ÁÖ¿ä ¹æ±¤¾Ï °ËÃâ ŰƮ ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

  • Abbott Laboratories
  • Xiamen Biotime Biotechnology
  • Abingdon Health
  • Ameritek
  • Alfa Scientific Designs
  • NanoEnTek
  • Exact Sciences
  • Hubei Jinjian Biology
  • Nanjing Liming Bio-Products
  • Diagnosis

Q6. ÇâÈÄ ÃÖ´ë°¡ µÇ´Â ½ÃÀå ºÎ¹®Àº?

A6. LucintelÀº FISH(Fluorescent In Situ Hybridization)°¡ ÀÌ ºÐ¾ß¿¡¼­ »ç¿ëµÇ´Â »õ·Î¿î ¼Òº¯ °Ë»ç ±â¼úÀÌ Á÷Á¢ Ç¥ÁöµÈ Çü±¤ DNA ÇÁ·Îºê¸¦ »ç¿ëÇϰí, ¼Òº¯À» Æ÷ÇÔÇÑ ¿ä·Î »óÇÇ ¼¼Æ÷ À¯ÀüÀÚ ÀÌ»óÀ» °Ë»çÇϱ⠶§¹®¿¡ ¿¹Ãø±â°£ µ¿¾È ÃÖ´ë ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

Q7. ½ÃÀå¿¡¼­ ÇâÈÄ 5³â µ¿¾È ÃÖ´ë°¡ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?

A7. ºÏ¹Ì¿¡¼­´Â ¹æ±¤¾Ï ¹ß»ý·üÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ ¿¹Ãø±â°£ Áß¿¡µµ ÃÖ´ë Áö¿ªÀÔ´Ï´Ù.

Q8. º¸°í¼­ Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´É?

A8. ³×, LucintelÀº Ãß°¡ ºñ¿ë ¾øÀÌ 10% Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå : ½ÃÀå ¿ªÇÐ

  • ¼­·Ð, ¹è°æ, ºÐ·ù
  • °ø±Þ¸Á
  • ¾÷°è ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼® : 2018-2030³â

  • °Å½Ã°æÁ¦ µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå : ±â¼úº°
    • FISH(Fluorescent In Situ Hybridization)
    • È¿¼Ò°áÇո鿪ÈíÂø ÃøÁ¤¹ý
    • ±âŸ
  • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå : ÃÖÁ¾ ÀÌ¿ë »ê¾÷º°
    • º´¿ø¡¤Áø·á¼Ò
    • Áø´Ü ¼¾ÅÍ
    • ±âŸ

Á¦4Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼® : Áö¿ªº°(2018-2030³â)

  • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå : Áö¿ªº°
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦5Àå °æÀï ºÐ¼®

  • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
  • ¿î¿µ»ó ÅëÇÕ
  • Porter's Five Forces ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

  • ¼ºÀå ±âȸ ºÐ¼®
    • ±â¼úº°
    • ÃÖÁ¾ ÀÌ¿ë »ê¾÷º°
    • Áö¿ªº°
  • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå Ãֽе¿Çâ
  • Àü·«Àû ºÐ¼®
    • ½ÅÁ¦Ç° °³¹ß
    • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå ´É·Â È®´ë
    • ¼¼°èÀÇ ¹æ±¤¾Ï °ËÃâ ŰƮ ½ÃÀå ÇÕº´, Àμö, ÇÕÀÛÅõÀÚ
    • ÀÎÁõ°ú ¶óÀ̼±½Ì

Á¦7Àå À¯·Â ±â¾÷ÀÇ ±â¾÷ °³¿ä

  • Abbott Laboratories
  • Xiamen Biotime Biotechnology
  • Abingdon Health
  • Ameritek
  • Alfa Scientific Designs
  • NanoEnTek
  • Exact Sciences
  • Hubei Jinjian Biology
  • Nanjing Liming Bio-products
  • Diagnosis
KSM 24.03.08

Bladder Cancer Detective Kit Trends and Forecast

The future of the global bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets. The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030 with a CAGR of 11.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

A more than 150-page report is developed to help in your business decisions.

Bladder Cancer Detective Kit by Segment

The study includes a forecast for the global bladder cancer detective kit by technology, end use industry, and region.

Bladder Cancer Detective Kit Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Fluorescence In Situ Hybridization
  • Enzyme-Linked Immunosorbent Assay
  • Others

Bladder Cancer Detective Kit Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Bladder Cancer Detective Kit Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bladder Cancer Detective Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bladder cancer detective kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bladder cancer detective kit companies profiled in this report include-

  • Abbott Laboratories
  • Xiamen Biotime Biotechnology
  • Abingdon Health
  • Ameritek
  • Alfa Scientific Designs
  • NanoEnTek
  • Exact Sciences
  • Hubei Jinjian Biology
  • Nanjing Liming Bio-Products
  • Diagnosis

Bladder Cancer Detective Kit Market Insights

Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Within this market, hospitals & clinics will remain the largest segment due to advancements in hospital infrastructure worldwide.

North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Features of the Global Bladder Cancer Detective Kit Market

Market Size Estimates: Bladder cancer detective kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bladder cancer detective kit market size by technology, end use industry, and region in terms of value ($B).

Regional Analysis: Bladder cancer detective kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, end use industry, and regions for the bladder cancer detective kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bladder cancer detective kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bladder cancer detective kit market size?

Answer: The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030.

Q2. What is the growth forecast for bladder cancer detective kit market?

Answer: The global bladder cancer detective kit market is expected to grow with a CAGR of 11.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bladder cancer detective kit market?

Answer: The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

Q4. What are the major segments for bladder cancer detective kit market?

Answer: The future of the bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets.

Q5. Who are the key bladder cancer detective kit market companies?

Answer: Some of the key bladder cancer detective kit companies are as follows.

  • Abbott Laboratories
  • Xiamen Biotime Biotechnology
  • Abingdon Health
  • Ameritek
  • Alfa Scientific Designs
  • NanoEnTek
  • Exact Sciences
  • Hubei Jinjian Biology
  • Nanjing Liming Bio-Products
  • Diagnosis

Q6. Which bladder cancer detective kit market segment will be the largest in future?

Answer: Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Q7. In bladder cancer detective kit market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bladder cancer detective kit market by technology (fluorescence in situ hybridization, enzyme-linked immunosorbent assay, and others), end use industry (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bladder Cancer Detective Kit Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bladder Cancer Detective Kit Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bladder Cancer Detective Kit Market by Technology
    • 3.3.1: Fluorescence In Situ Hybridization
    • 3.3.2: Enzyme-Linked Immunosorbent Assay
    • 3.3.3: Others
  • 3.4: Global Bladder Cancer Detective Kit Market by End Use Industry
    • 3.4.1: Hospitals & Clinics
    • 3.4.2: Diagnostic Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bladder Cancer Detective Kit Market by Region
  • 4.2: North American Bladder Cancer Detective Kit Market
    • 4.2.2: North American Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.3: European Bladder Cancer Detective Kit Market
    • 4.3.1: European Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
    • 4.3.2: European Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Bladder Cancer Detective Kit Market
    • 4.4.1: APAC Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
    • 4.4.2: APAC Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Bladder Cancer Detective Kit Market
    • 4.5.1: ROW Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
    • 4.5.2: ROW Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Technology
    • 6.1.2: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by End Use Industry
    • 6.1.3: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Region
  • 6.2: Emerging Trends in the Global Bladder Cancer Detective Kit Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bladder Cancer Detective Kit Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bladder Cancer Detective Kit Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Xiamen Biotime Biotechnology
  • 7.3: Abingdon Health
  • 7.4: Ameritek
  • 7.5: Alfa Scientific Designs
  • 7.6: NanoEnTek
  • 7.7: Exact Sciences
  • 7.8: Hubei Jinjian Biology
  • 7.9: Nanjing Liming Bio-products
  • 7.10: Diagnosis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦